Compare CDNA & JFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CDNA | JFR |
|---|---|---|
| Founded | 1998 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 712.2M | 1.3B |
| IPO Year | 2014 | N/A |
| Metric | CDNA | JFR |
|---|---|---|
| Price | $20.43 | $7.84 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $26.00 | N/A |
| AVG Volume (30 Days) | ★ 816.3K | 621.7K |
| Earning Date | 11-04-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.31% |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.22 | N/A |
| Revenue | ★ $357,998,000.00 | N/A |
| Revenue This Year | $14.11 | N/A |
| Revenue Next Year | $12.00 | N/A |
| P/E Ratio | $16.92 | ★ N/A |
| Revenue Growth | ★ 14.46 | N/A |
| 52 Week Low | $10.96 | $7.61 |
| 52 Week High | $25.95 | $8.82 |
| Indicator | CDNA | JFR |
|---|---|---|
| Relative Strength Index (RSI) | 71.98 | 45.41 |
| Support Level | $18.36 | $7.80 |
| Resistance Level | $19.95 | $7.96 |
| Average True Range (ATR) | 0.86 | 0.05 |
| MACD | 0.19 | 0.00 |
| Stochastic Oscillator | 99.42 | 42.50 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Nuveen Floating Rate Income Fund is a diversified closed-end management investment company. Its investment objective is to achieve a high level of current income. The fund invests a majority of its managed assets in secured Senior Loans and unsecured Senior Loans, with an average duration of one year or less, in which unsecured Senior Loans will be, at the time of investment, investment grade quality.